+100%-

Geoff’s Narrations

The GIST

 

This is the second blog to emanate from the 2025 IACFS/ME workshop. It covers Kunihisa Miwa’s presentation on disequilibrium in ME/CFS. Japanese researchers have consistently contributed interesting work on ME/CFS, and Kunihisa Miwa is a good example.

IACFS-ME Conference

This is the second blog to emanate from the 2025 IACFS/ME Conference. More are coming.

Miwa, who runs a clinic in Japan, appears to be something of a lone wolf. He’s been publishing interesting, kind of off-the-beaten-path ME/CFS studies, authored by him and sometimes by others, since 2008. That year, he introduced the idea of “small heart syndrome” in ME/CFS and subsequently published four more studies on it.

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

If not for Miwa, we also wouldn’t know that the renin-aldosterone-angiotensin paradox – possibly a key problem – exists in ME/CFS. In 2020, Miwa introduced the idea that postural instability or disequilibrium was a more important cause of the orthostatic intolerance (symptoms caused by being upright) in ME/CFS than POTS. He also pioneered the use of repetitive transcranial magnetic stimulation in ME/CFS.

Miwa’s recent study, “Static and Kinetic Disequilibrium are Central Neural Signs in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation“, used the Romberg to test for static disequilibrium (standing) and the tandem gait test with turn and return to test for kinetic disequilibrium (walking). Again, he used rTMS in an attempt to alleviate symptoms.

The GIST

  • This is the second of a series of blogs emanating from the 2025 IACFS/ME conference.
  • Kunishi Miwa, a Japanese researcher, presented the intriguing idea that something called disequilibrium or postural instability (the inability to stand and walk without swaying) was contributing to orthostatic intolerance (inability to be upright without symptoms).
  • His large study in his clinic found that 25% and 44% of ME/CFS patients, respectively, exhibited disequilibrium while standing or walking. Miwa used the Romberg test (see blog for how to do it) and a tandem walking test to assess his patients. He also used a 10-minute standing test.
  • The fact that almost all of his patients with POTS were able to complete the standing test while almost all of his patients with disequilibrium were not able to, convinced him that disequilibrium plays a more important role in orthostatic intolerance than POTS.
  • Other studies have documented (sometimes in smaller amounts) that disequilibrium is a part of ME/CFS, fibromyalgia, and long COVID for at least some patients.
  • They have also found  that disequilibrium contributes to fatigue due to the need for muscles to constantly try to balance the body, by the muscle bracing that is often seen, and the cognitive drain caused by the need to use the eyes to orient oneself in one’s physical environment.
  • One ME/CFS study found that when asked to solve a simple math problem, many people with ME/CFS had to stop their walk to do so – a clear sign that they were already being cognitively stressed.
  • Believing that neuroinflammation in the brain stem area was causing the disequilibrium, Miwa used minocycline and repetitive transcranial magnetic stimulation (rTMS) – both of which can tamp down neuroinflammation – to address the situation
  • Both were successful. Both resulted in dramatic reductions in disequilibrium. In his presentation, Miwa reported on a patient who was unstable while standing or walking but became stable after rTMS.
  • Note, though, that the study was not placebo-controlled, and because it involved recently ill patients, they might have improved on their own. Plus the dropout rate in one of Miwa’s minocycline studies was very high (44%). Still, the studies provide good preliminary evidence that could set the stage for larger trials.
  • In conclusion, if Miwa is right and disequilibrium is contributing to problems with standing, then the treatment focus shifts a bit. While we know that reduced blood flows to the brain are contributing to the orthostatic intolerance in ME/CFS and long COVID, the disequilibrium hypothesis suggests that treatments to reduce neuroinflammation could be helpful as well. That’s not a bad finding, given the work underway in many diseases to find ways to reduce neuroinflammation.

Health Rising’s Donation Drive Update!

thoughtful piggy

We look into everything we can. If you appreciate that, please support us!

Thanks to the dozens of people who have contributed over $4,000 to HR’s year-end fundraising drive. This illustrates one of Health Rising’s strengths – its breadth. When Miwa found small hearts in ME/CFS, we covered it. When Miwa demonstrated that the renin-aldosterone paradox could be causing the low blood volume issues in ME/CFS, we covered it – in spades. (It’s shown up in at least five blogs).

Now we’re onto disequilibrium – a known issue in these diseases, which, yes, we covered, and which Miwa is bringing a fresh look at. If you appreciate that kind of thoroughness and depth, please support us!

 

Support Health Rising and Keep the Information Flowing!

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

 

The Romberg Test

If I remember correctly, Dr. Cheney used the Romberg test, and Dr. Bateman has reported that the test is often positive in ME/CFS. The test is very simple. You stand, put your hands on your hips and you close your eyes for 30 seconds. (Another variation of the test has you put your arms out from your shoulders in so that you’re forming a cross.)

How to Assess Balance and Proprioception – Romberg Test – Clinical Skills – Dr Gill

Ten years ago I failed it – this time I passed it (:))

This large study (n=160 patients) found static disequilibrium in 25% and kinetic disequilibrium in 44% of participants. The ability to maintain “postural control,” i.e., stay steady without swaying, is controlled by pathways emanating from the brainstem. When they are impaired, we use our eyes to compensate for the loss of automatic control and maintain an upright posture. A 2015 study indicated how that happens in ME/CFS.

Thinking and Walking at the Same Time: Not a Good Idea in ME/CFS

This fascinating study asked people with ME/CFS and healthy controls to try to walk and think at the same time, exploring gait issues in ME/CFS. The study asked them to walk with eyes open, close their eyes, and walk and stop, and while they were walking, asked them what 100-7 was.

dizziness

Miwa believes deep brain issues are contributing to, or even causing, orthostatic intolerance in some people.

If the person suddenly looked at the ground to place their feet, or became clumsy when they closed their eyes, or if their gait went wonky, or they stopped walking to figure out what 100-7 was, something was off.

About 25% of the ME/CFS patients looked down at their feet before they began walking, compared to 1% of the healthy controls. The gait of almost 90% of the ME/CFS patients deteriorated slightly or greatly when they closed their eyes, compared to only 11% of the healthy controls.

Finally, 56% of the ME/CFS patients stopped walking to figure out that knotty math problem 🙂 (100-7=?), while only 5% of the healthy controls did. This may be why it’s harder for some people with these diseases to maintain a conversation while walking.

Disequilibrium – A Key Factor?

Why does Miwa believe that disequilibrium is a more important feature of orthostatic intolerance than POTS? In the studies he’s done, patients who failed the 10-minute stand test almost uniformly experienced disequilibrium when standing, but only a small percentage also had POTS. Remarkably, all the POTS patients completed the 10-minute standing test (was their POTS treated?).

While larger studies are needed, the fact that patients with disequilibrium had the worst general health (PS scores) suggests that disequilibrium may be synonymous with poorer health in these diseases.

Fatigue

Disequilibrium can contribute to fatigue in several ways.

Disequilibrium can cause fatigue in several ways. Parkinson’s studies have shown that maintaining stability in the presence of instability is “metabolically expensive”. For one, it takes extra muscular effort to continually be aligning yourself while upright. It’s also cognitively challenging. When I had stability issues, I noticed that I had to consciously look around to orient myself. Plus, being unsure of where you are in physical space may cause you to brace, and that muscle tension burns up a lot of energy.

Finally, all of this could put more stress on what may be a failing sympathetic nervous system.

Treatment

Minocycline

Miwa’s small studies suggest that both rTMS or minocycline may be able to help with the disequilibrium issue. His recent 55-person, non-placebo-controlled, minocycline trial began after a patient of his reported that she’d recovered after using minocycline.

Why use an antibiotic to combat a central nervous system problem? Because minocycline is an unusual antibiotic. It’s able to cross the blood-brain barrier, and can reduce microglial activation, the production of inflammatory cytokines in the brain, and neuroinflammation. For instance, it’s been used to treat traumatic brain injury.

brain on fire

Miwa believes neuroinflammation in the brain is affecting the parts of the brain that control balance and gait.

In the pilot study, ME/CFS patients received oral minocycline (100 mg × 2 on the first day, followed by 100 mg/day for 41 days). Miwa reported that 76% of the 21 patients with disequilibrium no longer had it by the end of the study. Seven of the eight patients who couldn’t complete the 10-minute standing test were able to complete it.

Miwa created his own “performance status” score sheet, which looks much like the functionality score sheet created by David Bell, MD, for ME/CFS. The average PS increase (2 points) would translate to something like “a noticeable increase” in what you can do day to day.

There are some big provisos to this finding, though. The study was open-label (everyone knew what they were getting), there was no control group, and only a single clinician/clinic was involved. Plus, the fact that Miwa found that recently diagnosed ME/CFS patients improved the most could reflect that they were already gradually improving. Plus, while only 7% of patients weren’t able to finish this trial in an earlier study, a whopping 38% of patients didn’t.

Basically, the results cannot be trusted, but they do provide a nice basis for a bigger, more rigorous trial.

The rTMS trial

Miwa used rTMS over the DLPFC and M1 to enhance activity in the brainstem vestibular centers. These centers help us orient ourselves in space.

The rTMS was focused on the left dorsolateral prefrontal cortex (DLPFC) and the left primary motor cortex. Why would Miwa target the prefrontal cortex and the motor cortex – neither of which are located anywhere near the brainstem? Because these parts of the brain communicate with each other, and studies have shown that targeting these areas affects vestibular functioning in the brainstem. DLPFC inactivation has been observed in several studies and has been proposed by both UK and Japanese researchers to play a key role in the brain network underlying fatigue.

The 30-person 2023 ME/CFS study found that after rTMS, 10 out of 12 patients who were unable before were now able to complete the 10-minute standing testing, disequilibrium was resolved in 15 (88%) out of 17 patients, and neuropathic pain was reduced in seven (70%) out of 10 patients. Another small ME/CFS rTMS trial found, interestingly, that blood flows to the frontal lobes improved.

prefrontal cortex

Miwa targeted an area of the brain – the dorsolateral prefrontal cortex – known to impact vestibular functioning. (The image shows the prefrontal cortex).

rTMS has received the most study in fibromyalgia. A systematic review of rTMS in FM concluded that rTMS reduces pain intensity and improves depressive symptoms, anxiety, and general health but that methodological issues (as always) were present. While methodological problems are present, enough studies have been done to identify a specific target and dose (M1 at 10 Hz) that helps. Miwa also targeted the motor cortex (M1) and the DLPFC, and used slightly different pulses. In another argument for going low and going slow, he had to reduce stimulation intensity for most patients.

While data suggests that rTMS may help with FM and ME/CFS, it won’t eliminate either condition. It may, though, be able to help with pain, disequilibrium, mood/anxiety, overall health, and quality of life.

Conclusion

If Miwa is right and disequilibrium is contributing to problems with standing, then the treatment focus shifts a bit. While we know that reduced blood flows to the brain are contributing to the orthostatic intolerance in ME/CFS and long COVID, the disequilibrium hypothesis suggests that treatments to reduce neuroinflammation could be helpful as well. That’s not a bad finding, given the work underway in many diseases to find ways to reduce neuroinflammation.

new approach

Once again, Miwa has introduced a new concept into ME/CFS.

Miwa reported that the oft-used tilt-table test can detect only orthostatic intolerance due to circulatory issues (reduced blood flow to the brain). Tests such as the Romberg and tandem walk tests are needed to detect orthostatic intolerance (symptoms triggered by standing) caused or contributed to by deep-brain issues.

Time will tell if Miwa or somebody else gets the funding to test his hypothesis. It would be great to see a study that assessed disequilibrium and performed brain scans before and after treatments.

Donation Drive Update

thoughtful piggy

We look into everything we can. If you appreciate that, please support us!

Thanks to the dozens of people who have contributed over $4,000 to HR’s year-end fundraising drive. This illustrates one of Health Rising’s strengths – its breadth. When Miwa found small hearts in ME/CFS, we covered it. When Miwa demonstrated that the renin-aldosterone paradox could be causing the low blood volume issues in ME/CFS, we covered it – in spades. (It’s shown up in at least five blogs).

Now we’re onto disequilibrium – a known issue in these diseases, which, yes, we covered, and which Miwa is bringing a fresh look at. If you appreciate that kind of thoroughness and depth, please support us!

 

Support Health Rising and Keep the Information Flowing!

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

 

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This